Corchado Sara, Márquez Mercedes, Montes de Oca Montserrat, Romero-Cores Paula, Fernández-Gutiérrez Clotilde, Girón-González José-Antonio
Unidad de Enfermedades Infecciosas, Hospital Universitario Puerta del Mar, Cádiz, Spain.
PLoS One. 2013 Jun 26;8(6):e66619. doi: 10.1371/journal.pone.0066619. Print 2013.
Analysis of the contribution of genetic (single nucleotide polymorphisms (SNP) at position -238 and -308 of the tumor necrosis factor alpha (TNF-α) and -592 of the interleukin-10 (IL-10) promotor genes) and of classical factors (age, alcohol, immunodepression, antirretroviral therapy) on the risk of liver cirrhosis in human immunodeficiency (HIV)-hepatitis C (HCV) virus coinfected patients.
Ninety one HIV-HCV coinfected patients (50 of them with chronic hepatitis and 41 with liver cirrhosis) and 55 healthy controls were studied. Demographic, risk factors for the HIV-HCV infection, HIV-related (CD4+ T cell count, antiretroviral therapy, HIV viral load) and HCV-related (serum ALT concentration, HCV viral load, HCV genotype) characteristics and polymorphisms at position -238 and -308 of the tumor necrosis factor alfa (TNF- α) and -592 of the interleukin-10 (IL-10) promotor genes were studied.
Evolution time of the infection was 21 years in both patients' groups (chronic hepatitis and liver cirrhosis). The group of patients with liver cirrhosis shows a lower CD4+ T cell count at the inclusion in the study (but not at diagnosis of HIV infection), a higher percentage of individuals with previous alcohol abuse, and a higher proportion of patients with the genotype GG at position -238 of the TNF-α promotor gene; polymorphism at -592 of the IL-10 promotor gene approaches to statistical significance. Serum concentrations of profibrogenic transforming growth factor beta1 were significantly higher in healthy controls with genotype GG at -238 TNF-α promotor gene. The linear regression analysis demonstrates that the genotype GG at -238 TNF-α promotor gene was the independent factor associated to liver cirrhosis.
It is stressed the importance of immunogenetic factors (TNF-α polymorphism at -238 position), above other factors previously accepted (age, gender, alcohol, immunodepression), on the evolution to liver cirrhosis among HIV-infected patients with established chronic HCV infections.
分析基因因素(肿瘤坏死因子α(TNF-α)启动子基因-238和-308位点以及白细胞介素-10(IL-10)启动子基因-592位点的单核苷酸多态性(SNP))和经典因素(年龄、酒精、免疫抑制、抗逆转录病毒治疗)对人类免疫缺陷病毒(HIV)-丙型肝炎病毒(HCV)合并感染患者肝硬化风险的影响。
研究了91例HIV-HCV合并感染患者(其中50例为慢性肝炎,41例为肝硬化)和55例健康对照。研究了人口统计学、HIV-HCV感染的危险因素、HIV相关因素(CD4+T细胞计数、抗逆转录病毒治疗、HIV病毒载量)和HCV相关因素(血清ALT浓度、HCV病毒载量、HCV基因型)以及肿瘤坏死因子α(TNF-α)启动子基因-238和-308位点以及白细胞介素-10(IL-10)启动子基因-592位点的多态性。
两组患者(慢性肝炎和肝硬化)的感染病程均为21年。肝硬化患者组在纳入研究时CD4+T细胞计数较低(但在HIV感染诊断时并非如此),既往有酒精滥用的个体比例较高,TNF-α启动子基因-238位点基因型为GG的患者比例较高;IL-10启动子基因-592位点的多态性接近统计学显著性。TNF-α启动子基因-238位点基因型为GG的健康对照中,促纤维化转化生长因子β1的血清浓度显著更高。线性回归分析表明,TNF-α启动子基因-238位点的基因型GG是与肝硬化相关的独立因素。
强调了免疫遗传因素(-238位点的TNF-α多态性)在已确诊慢性HCV感染的HIV感染患者发展为肝硬化过程中的重要性,其重要性高于先前公认的其他因素(年龄、性别、酒精、免疫抑制)。